| Literature DB >> 30026977 |
Michael K Y Hsin1, Chi Fong Wong2, See Wan Yan2, Katherine Y Fan3, Cally K L Ho1, Inderjeet Bhatia1, Timmy W K Au1.
Abstract
Clinical lung transplant was first performed in Hong Kong in 1995. In the early years, the volume of activity was very low. There has been a clear trend of increasing volume in the past few years. The recipient pathology is very different from the International Society for Heart and Lung Transplantation (ISHLT) database, with complete absence of cystic fibrosis and alpha-1-antitrypsin deficiency, and a predominance of diseases of the pulmonary circulation. Lymphangioleiomyomatosis (LAM) has a much higher representation on the waiting list than the ISHLT. The survival of patients who received a lung transplant in Hong Kong compares favorably with international data.Entities:
Keywords: Hong Kong; Lung transplantation
Year: 2018 PMID: 30026977 PMCID: PMC6035933 DOI: 10.21037/jtd.2018.04.118
Source DB: PubMed Journal: J Thorac Dis ISSN: 2072-1439 Impact factor: 2.895